Tumor bed radiosurgery: an emerging treatment for brain metastases Mark J. AmsbaughWarren BolingShiao Woo Topic Review 25 April 2015 Pages: 197 - 203
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients Johnny C. AkersValya RamakrishnanClark C. Chen Laboratory Investigation 23 April 2015 Pages: 205 - 216
Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells George A. AlexiouKonstantinos I. TsamisAthanasios P. Kyritsis Laboratory Investigation 03 May 2015 Pages: 217 - 224
Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion Shilpa S. PatilReema RailkarPaturu Kondaiah Laboratory Investigation 06 May 2015 Pages: 225 - 235
Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma Seiichiro HironoYasuo IwadateNaokatsu Saeki Clinical Study 25 April 2015 Pages: 237 - 244
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy Kim KramerNeeta Pandit-TaskarNai-Kong V. Cheung Clinical Study 06 May 2015 Pages: 245 - 249
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials Julie A. CarlsonKrishna ReddyChanghu Chen Clinical Study 29 April 2015 Pages: 251 - 257
BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial Stuart H. BurriRoshan S. PrabhuAnthony L. Asher Clinical Study 07 May 2015 Pages: 259 - 266
Which one is a valuable surrogate for predicting survival between Tomita and Tokuhashi scores in patients with spinal metastases? A meta-analysis for diagnostic test accuracy and individual participant data analysis Chang-Hyun LeeChun Kee ChungStephane Fuentes Clinical Study 07 May 2015 Pages: 267 - 275
Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma Seema NagpalCathy Kahn RechtLawrence D. Recht Clinical Study Open access 03 May 2015 Pages: 277 - 282
Calcification in high grade gliomas treated with bevacizumab Deborah T. BlumenthalOrna AisensteinFelix Bokstein Clinical Study 05 May 2015 Pages: 283 - 288
MRI findings and pathological features in early-stage glioblastoma Makoto IdeguchiKoji KajiwaraMichiyasu Suzuki Clinical Study 05 May 2015 Pages: 289 - 297
Age-associated brain regions in gliomas: a volumetric analysis Yinyan WangShuai LiuWenbin Ma Clinical Study 16 May 2015 Pages: 299 - 306
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival Marcos A. dos SantosJean-Pierre PignonGwénaël Le Teuff Clinical Study 15 May 2015 Pages: 307 - 314
Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma Carl A. GoldAndrew B. LassmanYazmín Odia Letter to the Editor 12 April 2015 Pages: 315 - 316
Influence of 1p19q status and Ki67 index to predict extent of resection in WHO grade II gliomas: a virtual patient model Dominik CordierSabine SchädelinHugues Duffau Letter to the Editor 28 April 2015 Pages: 317 - 318
SmART-ER imaging and treatment of glioblastoma Patrick V. GrantonSanaz YahyanejadMarc A. Vooijs Letter to the Editor 08 May 2015 Pages: 319 - 320
